PharmaCielo Ltd.

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: CA71716K1012
CAD
0.06
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Cannara Biotech, Inc.
MediPharm Labs Corp.
Greenway Greenhouse Cannabis Corp.
Avant Brands, Inc.
Leef Brands, Inc.
PharmaCielo Ltd.
Charlotte's Web Holdings, Inc.
CanadaBis Capital, Inc.
C21 Investments, Inc.
BYND Cannasoft Enterprises, Inc.
Gold Flora Corp.

Why is PharmaCielo Ltd. ?

1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate 13.80% of over the last 5 years
  • The company has a negative book value of Rs 15.35 crore
2
Flat results in Sep 25
  • NET SALES(HY) At CAD 1.21 MM has Grown at -42.65%
  • RAW MATERIAL COST(Y) Grown by 252.94% (YoY)
  • OPERATING PROFIT(Q) Lowest at CAD -2.33 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 10.00%, its profits have risen by 50.2%
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 10.00% in the last 1 year, much lower than market (S&P/TSX 60) returns of 30.39%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is PharmaCielo Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
PharmaCielo Ltd.
10.0%
-0.26
248.84%
S&P/TSX 60
30.39%
2.45
12.39%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-0.30%
EBIT Growth (5y)
13.80%
EBIT to Interest (avg)
-16.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.71
Sales to Capital Employed (avg)
0.34
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.18%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.86
EV to EBIT
-8.24
EV to EBITDA
-11.15
EV to Capital Employed
10.49
EV to Sales
12.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-127.31%
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CAD -1.94 MM

NET PROFIT(HY)

Higher at CAD -2.42 MM

-6What is not working for the Company
NET SALES(HY)

At CAD 1.21 MM has Grown at -42.65%

RAW MATERIAL COST(Y)

Grown by 252.94% (YoY

OPERATING PROFIT(Q)

Lowest at CAD -2.33 MM

Here's what is working for PharmaCielo Ltd.

Operating Cash Flow
Highest at CAD -1.94 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Net Profit
Higher at CAD -2.42 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Here's what is not working for PharmaCielo Ltd.

Net Sales
At CAD 1.21 MM has Grown at -42.65%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CAD MM)

Operating Profit
Lowest at CAD -2.33 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CAD MM)

Raw Material Cost
Grown by 252.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales